These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9808667)

  • 1. Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides.
    Fitzgerald LW; Patterson JP; Conklin DS; Horlick R; Largent BL
    J Pharmacol Exp Ther; 1998 Nov; 287(2):448-56. PubMed ID: 9808667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of third intracellular loop of galanin receptor type 1 in signal transduction.
    Rezaei K; Saar K; Soomets U; Valkna A; Näsman J; Zorko M; Akerman K; Schroeder T; Bartfai T; Langel U
    Neuropeptides; 2000 Feb; 34(1):25-31. PubMed ID: 10688965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of agonist and antagonist ligand-binding parameters at the human parathyroid hormone type 1 receptor: evaluation of receptor states and modulation by guanine nucleotide.
    Hoare SR; de Vries G; Usdin TB
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1323-33. PubMed ID: 10336523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin receptors in human basal forebrain differ from receptors in the hypothalamus: characterization using [125I]galanin (porcine) and [125I]galantide.
    Deecher DC; Odusan OO; Mufson EJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):720-7. PubMed ID: 7473159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes.
    Lu X; Lundström L; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):165-7. PubMed ID: 15944007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists.
    Lang R; Berger A; Santic R; Geisberger R; Hermann A; Herzog H; Kofler B
    Neuropeptides; 2005 Jun; 39(3):179-84. PubMed ID: 15944009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for hydrophobic interaction between galanin and the GalR1 galanin receptor and GalR1-mediated ligand internalization: fluorescent probing with a fluorescein-galanin.
    Wang S; Clemmons A; Strader C; Bayne M
    Biochemistry; 1998 Jun; 37(26):9528-35. PubMed ID: 9649336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice.
    Badie-Mahdavi H; Lu X; Behrens MM; Bartfai T
    Neuroscience; 2005; 133(2):591-604. PubMed ID: 15885916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors.
    Sullivan KA; Shiao LL; Cascieri MA
    Biochem Biophys Res Commun; 1997 Apr; 233(3):823-8. PubMed ID: 9168941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides.
    Kamohara M; Matsuo A; Takasaki J; Kohda M; Matsumoto M; Matsumoto S; Soga T; Hiyama H; Kobori M; Katou M
    Biochem Biophys Res Commun; 2005 May; 330(4):1146-52. PubMed ID: 15823563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
    Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
    Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
    Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM; Wille S
    Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells.
    Kask K; Berthold M; Bourne J; Andell S; Langel U; Bartfai T
    Regul Pept; 1995 Nov; 59(3):341-8. PubMed ID: 8577939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
    Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
    Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of central galanin administration on muscarinic cholinergic and galanin receptor G protein coupling.
    Barreda-Gómez G; Giralt MT; Rodríguez-Puertas R
    Neuropeptides; 2005 Jun; 39(3):157-60. PubMed ID: 15944005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and expression of the human galanin receptor GalR2.
    Bloomquist BT; Beauchamp MR; Zhelnin L; Brown SE; Gore-Willse AR; Gregor P; Cornfield LJ
    Biochem Biophys Res Commun; 1998 Feb; 243(2):474-9. PubMed ID: 9480833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galanin and galanin receptors in human gliomas.
    Berger A; Santic R; Almer D; Hauser-Kronberger C; Huemer M; Humpel C; Stockhammer G; Sperl W; Kofler B
    Acta Neuropathol; 2003 Jun; 105(6):555-60. PubMed ID: 12734662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.